Tom Mazurek
About Tom Mazurek
Tom Mazurek, age 58, is Chief Supply Chain Officer at Bath & Body Works (BBWI) and has been with the company since 2000, becoming CSCO in May 2022. He leads product development, R&D/engineering, global manufacturing/sourcing, and enterprise sustainability, and was a key contributor to “Beauty Park,” the company’s integrated partner manufacturing hub; earlier in his career he held operational roles at Hasbro and Mattel . He holds a B.S. from Fordham University and an MBA from the University at Buffalo . Company performance context during his tenure as a named executive includes FY2024 net sales of $7,307 million, net income of $798 million, and adjusted operating income of $1,266 million (equal to GAAP operating income in 2024), with five-year cumulative TSR turning $100 into $218.10 by FY2024; incentive design emphasizes adjusted operating income, net sales (short-term), and operating income margin and relative TSR (long-term) .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Bath & Body Works | Chief Supply Chain Officer | May 2022–present | Leads product development, manufacturing/sourcing across global suppliers, and enterprise sustainability . |
| Bath & Body Works | Progressive supply chain/operations roles | 2000–2022 | Key contributor to “Beauty Park,” co-located partner manufacturing near Ohio DCs/HQ to improve speed and efficiency . |
| Hasbro | Operational roles | Not disclosed | Early career operating experience . |
| Mattel | Operational roles | Not disclosed | Early career operating experience . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| — | — | — | No public company or other external roles disclosed for Mazurek in the latest proxy . |
Fixed Compensation
| Year | Base Salary ($) | Target Bonus (%) | Actual Short‑Term Incentive ($) | All Other Compensation ($) | Total Compensation ($) |
|---|---|---|---|---|---|
| 2024 | 700,000 | 100% | 697,480 | 25,931 | 2,926,254 |
Performance Compensation
Short‑Term Incentive (STI) – Design and Outcomes (FY2024)
| Metric | Weight | Target | Actual | Payout |
|---|---|---|---|---|
| Adjusted Operating Income | 75% | Not disclosed | Spring above target; Fall below target | Contributed to total 99.6% of target payout |
| Net Sales (absolute) | 25% | Not disclosed | Below target for both Spring and Fall | Contributed to total 99.6% of target payout |
| Season | STI Payout ($) | Notes |
|---|---|---|
| Spring 2024 | 306,880 | AOI above target; Sales below target |
| Fall 2024 | 390,600 | Both AOI and Sales below target |
| Total FY2024 | 697,480 (99.6% of target) | — |
Long‑Term Incentives (LTI) – Current Grants and Structure
| Grant Date | Award Type | Target Shares (#) | Grant Date Fair Value ($) | Performance Metrics | Vesting |
|---|---|---|---|---|---|
| 3/13/2024 | PSUs | 16,246 | 786,469 | 50% Operating Income Margin; 50% Relative TSR vs S&P 500 Consumer Discretionary Distribution & Retail; “negative absolute TSR cap” | Cliff vest March 2027, subject to performance and service |
| 3/13/2024 | RSUs | 16,248 | 716,374 | Time‑based | 30% after 1 year, 30% after 2 years, 40% after 3 years (3/13/2025; 3/13/2026; 3/13/2027) |
| 5/2022 | Retention PSUs | 18,055 target; 12,097 earned | Not disclosed | Performance‑based retention grant (CEO transition period) | Vested in 2024 based on interpolated performance |
Stock Options (Outstanding)
| Grant Date | Options Exercisable (#) | Exercise Price ($) | Expiration |
|---|---|---|---|
| 4/2/2015 | 2,547 | 73.58 | 4/2/2025 |
| 3/31/2016 | 4,232 | 70.87 | 3/31/2026 |
| 3/16/2021 | 4,933 | 48.64 | 3/16/2031 |
Equity Ownership & Alignment
Beneficial Ownership (as of April 8, 2025)
| Holder | Shares Beneficially Owned (#) | Percent of Class | Shares Issuable within 60 Days (#) |
|---|---|---|---|
| Tom Mazurek | 27,311.577 | <1% | 5,671 |
- Stock ownership guidelines: 3x base salary for NEOs; compliance required within five years; all NEOs are either in compliance or on track .
- Hedging prohibited; pledging prohibited without approval; none of the Company’s stock held by NEOs or directors is pledged .
Equity Vested and Exercises (FY2024)
| Item | Quantity (#) | Value Realized ($) |
|---|---|---|
| Options Exercised | 2,285 | 11,751 |
| RSUs/PSUs Vested | 27,029 | 1,220,252 |
Outstanding Unvested/Unearned Awards at FY‑End (Feb 1, 2025)
| Grant Date | Award Type | Unvested/Unearned (#) | Market Value ($ at $37.61) | Vesting Schedule |
|---|---|---|---|---|
| 3/9/2022 | RSUs | 2,516 | 94,627 | Vested on 3/9/2025 |
| 3/9/2022 | PSUs (target) | 6,291 | 236,605 | 100% vested on 3/9/2025, subject to performance |
| 5/19/2023 | RSUs | 13,233 | 497,693 | 43% on 5/19/2025; 57% on 5/19/2026 |
| 5/19/2023 | PSUs (target) | 18,902 | 710,904 | 100% on 5/19/2026, subject to performance |
| 3/13/2024 | RSUs | 16,248 | 611,087 | 30% on 3/13/2025; 30% on 3/13/2026; 40% on 3/13/2027 |
| 3/13/2024 | PSUs (target) | 16,246 | 611,012 | 100% on 3/13/2027, subject to performance |
Employment Terms
Severance and Change‑in‑Control Economics (Assuming termination date Feb 1, 2025; stock price $37.61)
| Component | Involuntary Without Cause / Voluntary with Good Reason (non‑CIC) | Involuntary Without Cause Following Change‑in‑Control | Death | Disability |
|---|---|---|---|---|
| Base Salary | 1,400,000 | — | — | — |
| Short‑Term Incentive (Cash) | 1,400,000 | — | — | — |
| Value of Vested Stock (accelerated per terms) | 796,825 | 1,882,646 | 1,882,646 | — |
| Benefits & Perquisites | 52,795 | 1,400,000 | 300,000 | — |
| Total | 3,649,620 | 3,282,646 | 2,182,646 | — |
Key terms and structure:
- Non‑CIC termination: 24 months of base salary continuation; two years of COBRA premiums; pro‑rated current‑season STI paid based on actual performance; additional two years of STI payouts based on actual performance; pro‑rata acceleration of time‑based awards; pro‑rata continued vesting for performance‑based awards subject to achievement .
- Change‑in‑control (double‑trigger): Upon qualifying termination within three months before or 24 months after a CIC, lump sum equal to the last four seasonal STI payouts plus pro‑rated current‑season STI (using average of prior four); full acceleration of unvested equity (PSUs deemed target if <1/3 of performance period elapsed; otherwise deemed maximum) .
- No excise tax gross‑ups under Section 280G/4999; no single‑trigger vesting .
- Clawbacks: Policy compliant with NYSE/Dodd‑Frank; supplemental recoupment allows recovery/cancellation for cause and related circumstances .
Performance & Track Record (role‑relevant highlights)
- Led end‑to‑end supply chain and sustainability; credited as key contributor to “Beauty Park,” integrating key manufacturing partners near BBWI’s Ohio logistics hub to enhance speed/cost .
- 2024 company execution: net sales $7,307m; net income $798m; delivered ~$155m of cost reductions in 2024, ~$300m+ over two years vs initial $200m target, supporting operating leverage focus .
- Incentive linkage: FY2024 STI paid slightly below target (99.6%) consistent with mixed performance (Spring above target; Fall below) and new metric mix adding absolute net sales (25%) alongside adjusted operating income (75%) .
- Legacy retention PSUs (May 2022) paid below target for Mazurek (12,097 earned vs 18,055 target), indicating measured performance calibration during CEO transition period .
Compensation Structure Analysis
- Mix shifts and rigor: For NEOs, PSUs constitute 50% of LTI with equal weighting of relative TSR and operating income margin and a negative absolute TSR cap; RSUs vest 30/30/40 over three years, supporting retention with staggered vests through 2027 .
- Year‑over‑year salary: NEO base salaries held flat since 2022, increasing relative weight of LTI (higher at‑risk pay mix) .
- Governance safeguards: No tax gross‑ups; no single‑trigger CIC vesting; anti‑hedging; no pledging (and none pledged); robust clawbacks .
Equity Ownership & Alignment (risk/pressure signals)
- Ownership: 27,311.577 shares beneficially owned (<1%); 5,671 shares issuable within 60 days, indicating modest direct ownership relative to float (skin‑in‑the‑game present but not concentrated) .
- Upcoming vesting cadence: Significant RSU tranches in 2025, 2026, 2027 and PSU cliffs in 2026/2027 may create periodic liquidity windows and potential selling pressure around vest dates (subject to 10b5‑1 plans and blackout policies) .
- 2024 realized equity: 27,029 shares vested; modest option exercise value realized, suggesting limited in‑the‑money leverage from legacy options at 2024 prices .
Employment Terms (retention/transition risk)
- Retention supports: Multi‑year cliff/performance PSU awards and staggered RSU vests (through March 2027) align continued service; severance provides income continuity without tax gross‑ups .
- CIC dynamics: Double‑trigger structure reduces entrenchment risk while ensuring competitive protections; PSU treatment shifts to target or max depending on elapsed performance period .
Investment Implications
- Alignment: Pay design is tightly linked to operating income margin and relative TSR (with downside “cap”), and STI mix leans toward profitability (75% AOI), aligning supply chain execution with shareholder value drivers .
- Retention risk: Substantial unvested RSUs/PSUs through 2027, coupled with 24‑month severance and continued/performance‑based vesting in non‑CIC terminations, lowers near‑term flight risk; 2022 retention PSU payout below target suggests performance discipline .
- Selling pressure: Concentrated vest dates in May/March of 2025–2027 and cliff PSU events (2026/2027) could be followed by discretionary sales; monitor 10b5‑1 filings/form 4s around these windows .
- Governance quality: No hedging, no pledging, robust clawbacks, and no CIC tax gross‑ups reduce governance red flags; no single‑trigger vesting and performance‑weighted LTI indicate shareholder‑friendly structure .